Biological Fluid–Mediated Transport Mechanisms for Targeted Drug Delivery in Next-Generation Cancer Immunotherapy

Biological Fluid-Mediated Transport Mechanisms for Targeted Drug Delivery in Next-Generation Cancer Immunotherapy addresses the critical need for innovative therapeutic platforms that improve efficacy and reduce toxicity in cancer treatment. The volume explores how natural biofluids and derived carriers, like exosomes and extracellular vesicles, can serve as highly biocompatible vehicles for delivering immunotherapeutics. It emphasizes their roles in overcoming barriers such as immune evasion, rapid clearance, and systemic side effects, while also leveraging biofluid signatures for real-time diagnostics through liquid biopsies. The book encompasses topics from the composition and biomolecular content of biofluids to the engineering strategies for functionalization, targeting, and controlled release, integrating cutting-edge nanotechnologies and microfluidics.This reference book supports the advancement of next-generation precision cancer immunotherapies by providing insights into biofluid dynamics, bioresponsive carriers, and personalized approaches. It bridges basic science with translational potential, fostering innovation in nanomedicine, immunology, and biomedical engineering, and aims to accelerate the clinical impact of biofluid-inspired drug delivery systems. - Explores biofluid-based platforms to optimize cancer immunotherapy - Integrates interdisciplinary perspectives from nanotechnology, immunology, and engineering - Highlights diagnostic and therapeutic roles of biofluids and extracellular vesicles - Discusses engineering strategies for functionalizing biofluid carriers - Addresses regulatory, scalability, and translational challenges